Clinical outcomes of trimetazidine in patients with acute ST segment elevation myocardial infarction without ST segment resolution after primary percutaneous coronary intervention

National Medical Journal of China

Volumn 89, Issue 20, 2009, Pages 1399-1401

  Peng, Jian Jun ^a   Ma, Zhi Min ^a   Ren, Wen Lin ^a   Ren, Li Hui ^a   Lei, Li Cheng ^a   Liang, Ya ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Myocardial infarction; Trimetazidine

Indexed keywords

TRIMETAZIDINE; VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; AGED; ELECTROCARDIOGRAPHY; HEART INFARCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 77954933694     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.20.012     Document Type: Article

References (11)

1. Siber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary intervention of the european society of cardiology. Eur Heart J, 2005,26:804-847.
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol, 2004,44:671-719.
3. Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombosis in myocardial infarction perfusion grade after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996,93:1993-1999.
4. Gingliano RP, Sabatine MS, Gibson CM, et al. Combined assessment of thrombosis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. Am J Cardiol, 2004,93: 1362-1367.
5. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction, Circulation, 2004,110: e506-e510.
6. Johanson P, Fu Y, Wagner GS, et al. ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3. Am J Cardiol, 2009,103:154-158.
7. Banach M, Rysz J, Goch A, et al. The role of trimetazidine after acute myocardial infarction. Curr Vasc Pharmacol, 2008,6:282-291.
8. Zeymer U, Schroder K, Wegscheider K, et al. ST resolution in single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction. Am Heart J, 2005,149:91-97.
9. Fragasso G, Palloshi A, Puccetti P, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol, 2006,48:992-998.
10. Steg PG, Grollier G, Gallay P, et al. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. Int J Cardiol, 2001, 77:263-273.